FPAS
IRWD icon

Focus Partners Advisor Solutions’s Ironwood Pharmaceuticals IRWD Stock Holding History

Focus Partners Advisor Solutions’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Sell
33,624
-28,448
-46% -$110K ﹤0.01% 1195
2026
Q1 		$218K Buy
62,072
+2,455
+4% +$10.1K ﹤0.01% 1123
2025
Q4 		$201K Buy
59,617
+7,322
+14% +$19K ﹤0.01% 1031
2025
Q3 		$113K Buy
52,295
+12,552
+32% +$13K ﹤0.01% 1093
2025
Q2 		$28.5K Buy
39,743
+29,409
+285% +$23.1K ﹤0.01% 1087
2025
Q1 		$15.2K Buy
+10,334
New +$24.6K ﹤0.01% 965

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Focus Partners Advisor Solutions's IRWD Position: Q2 2026 in Review

Focus Partners Advisor Solutions reduced its Ironwood Pharmaceuticals (IRWD) stake by 46% in Q2 2026, selling an estimated $110K and leaving 33,624 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #1195.

Focus Partners Advisor Solutions first reported a position in IRWD in Q1 2025 and has held it in 6 quarters since. The position peaked at $218K in Q1 2026. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Focus Partners Advisor Solutions held 33,624 shares of Ironwood Pharmaceuticals worth $142K as of Q2 2026.
  • Focus Partners Advisor Solutions sold 28,448 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $110K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #1195 holding.
  • Focus Partners Advisor Solutions first reported a position in Ironwood Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Focus Partners Advisor Solutions's Ironwood Pharmaceuticals position peaked at $218K in Q1 2026.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.